SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Medizone/OTC: MZEI (AIDS and Hepatitis B Treatment) -- Ignore unavailable to you. Want to Upgrade?


To: gtoland who wrote (772)5/31/2000 7:50:00 PM
From: gtoland  Read Replies (1) | Respond to of 783
 
This is even better..........

1st quarter 2003 $148,000,000
2nd quarter 2003 $173,000,000
3rd quarter 2003 $197,000,000
4th quarter 2003 $221,000,000

Accumulated totals $1,991,000,000 (BILLION)

They anticipate helping only .49 of the over 300,000,000 people with hep c.

This does not anticipated any other revenue from any other treatments Sales for the other viruses, ozone will kill. HIV, Animal, External uses, etc.

Is this a Penny Stock worth only .66 per share????